Skip to main content
VCbacked
Log inGet Started

Truly Technologies

Seattle, United States

Truly Technologies develops biospecimen processing technologies for diagnostic, therapeutic and life science research applications.

$273K raised
May 2023
Grant
BiotechnologyLife ScienceProduct Research

Top Investors

National Institute of Allergy and Infectious DiseasesCoMotionUniversity of Washington

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Truly Technologies

How much funding has Truly Technologies raised?
Truly Technologies has raised $273K in total funding. The most recent round was Grant. The last funding was announced in May 2023.
Who are Truly Technologies's investors?
Truly Technologies's investors include National Institute of Allergy and Infectious Diseases, CoMotion, University of Washington.
Where is Truly Technologies headquartered?
Truly Technologies is headquartered in Seattle, United States.
What does Truly Technologies do?
Truly Technologies develops biospecimen processing technologies for diagnostic, therapeutic and life science research applications.
What stage is Truly Technologies at?
Truly Technologies is at the Grant stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Truly Technologies — Funding & Investors." VCBacked, May 1, 2023, https://www.vcbacked.co/company/truly-technologies. Accessed July 3, 2026.
APA
VCBacked. (2023). Truly Technologies — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/truly-technologies
Wikipedia (cite web)
{{cite web |title=Truly Technologies — Funding & Investors |url=https://www.vcbacked.co/company/truly-technologies |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Rapport Therapeutics
Boston$250.0M
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K